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the physiology of how prelabour caesarean section (pcS) and induction of labour (ioL) in comparison 
to spontaneous vaginal delivery (SVD) has not been fully clarified yet. We measured 201 cord blood 
(CB) phospholipids and energy metabolites via LC/MS-MS in 109 newborns from the ROLO Kids study; 
metabolites were compared across the three parturition groups via linear mixed models with correction 
for multiple testing. In comparison to SVD, PCS babies had lower non-esterified fatty acids (NEFA), 
including sum of nefA (p < 0.001), and trends for lower acylcarnitines. The lack of hormonal stimuli, 
especially catecholamines and cortisol, may underlie the metabolic changes involving gluconeogenesis 
from fatty acid oxidation (FAO) in PCS born infants. IOL and SVD infants showed no significant 
differences in metabolites, but ratios estimating carnitine palmitoyltrasferase 1 activity (precursor for 
fAo) were slightly higher in ioL than in SVD. thus, ioL does not induce metabolic disadvantage when 
compared to SVD, though post-natal gluconeogenesis might start earlier due to the artificial solicitation 
in ioL. these data shed light on the physiology of parturition and may contribute to understand how 
mode of delivery might modulate future metabolic risks.
Caesarean section (CS) and induction of labour (IOL) are surgical and non-surgical approaches to facilitate birth 
in complicated pregnancies/deliveries or overdue mothers, but their widespread usage is controversial. While the 
WHO states that “[at] population level, caesarean section rates higher than 10% are not associated with reduc-
tions in maternal and newborn mortality rates”1, the worldwide rate of CS was estimated in 2016 to be of 18.6%2. 
Birth by CS has been associated, among others, with intestinal microbial colonization3 and increased risk for 
obesity4. Pre-labour (elective) CS (PCS) is of particular interest, as it seems to induce physiological changes able 
to trigger long-term health outcomes5,6. IOL, while recommended under specific circumstances7, is associated 
with several obstetrical complications8 and often met with adverse maternal perception9. The physiological mech-
anisms of how parturition, and especially IOL, can impact the offspring’s metabolism are largely unclear6.
Metabolomics is the study of small molecules which are intermediates or products of metabolic reactions and 
has found clinical applications in the mechanistic explanation of pathophysiological phenomena. Mode of deliv-
ery, however, has received little interest in metabolomics research so far. In 2009, Hyde et al. studied the hepatic 
metabolome of piglets after observing that PCS was associated with higher risk for hepatic steatosis than SVD10; 
four years later, Hashimoto and colleagues used metabolomics to explain the changes in cord blood saccharides 
associated with caesarean delivery11. However, no metabolomics studies have been carried out regarding IOL.
To overcome this paucity of information about how mode of delivery might impact the fetal/neonatal metab-
olism, we performed a descriptive analysis investigating the association of mode of delivery (SVD, PCS or IOL 
followed by vaginal delivery) with glucose, c-peptide and 201 metabolites (intermediates of energy metabolism 
and phospholipids) measured in cord blood. Moreover, we compared infant anthropometry at 6 months, 2, and 5 
years across the three mode of delivery groups and compared our population to epidemiological studies.
1Division of Metabolic and Nutritional Medicine, Department of Paediatrics, Dr. von Hauner Children’s Hospital, 
University Hospital, LMU Munich, Munich, Germany. 2UCD Perinatal Research Centre, Obstetrics and Gynaecology, 
School of Medicine, University College Dublin, National Maternity Hospital, Dublin, Ireland. *email: office.koletzko@
med.lmu.de
open
2Scientific RepoRtS |         (2019) 9:17562  | https://doi.org/10.1038/s41598-019-53810-1
www.nature.com/scientificreportswww.nature.com/scientificreports/
Methods
Subjects. The ROLO Study (Randomised cOntrol trial of LOw glycemic index diet versus no dietary inter-
vention to prevent recurrence of fetal macrosomia), a randomised control trial (RCT) conducted at the National 
Maternity Hospital, Dublin, Ireland between 2007 and 201212 (Current Controlled Trials ISRCTN54392969), 
investigated the hypothesis whether an isocaloric low-glycemic index (low-GI) diet in pregnancy could be ben-
eficial in the reduction of birth weight in a population at risk for macrosomia. The study was conducted by 
randomizing 800 secundigravid mothers with a previous macrosomic child (birthweight >4000 kg) and no 
underlying metabolic disorders to either receive an educational session about low-GI diet in pregnancy, or stand-
ard care only. No difference in the primary outcome, birthweight, was observed12. The data here presented have 
been collected at 6 months (6 m), 2 years (2 y) and 5 years (5 y) within the follow up of the ROLO Study, the ROLO 
Kids Study. Both studies were carried out in accordance with the Helsinki Declaration of 1975 as revised in 1983. 
Institutional ethical approval from the National Maternity Hospital was obtained in 2006 for the original ROLO 
study, and in 2009 for the ROLO Kids 6 months and 2 years follow-up. The ROLO Kids 5 years follow-up was 
approved by the Ethics (Medical Research) Committee in Our Lady’s Children’s Hospital, Dublin. Informed writ-
ten maternal consent was obtained during pregnancy and at each subsequent follow-up.
Anthropometry and clinical data collection. Maternal weight and height, education level, maternal 
smoking and paternal body mass index (BMI) were collected or measured at the first study visit (median ges-
tational week: 13th week) and maternal BMI was calculated. Gestational weight gain (GWG) was defined as the 
weight from the last visit pre-partum (38 weeks) minus the weight measured at booking visit. The socio-economic 
status was assessed by calculating the 2011 Pobal Haase & Pratschke Deprivation Index (HP Index) as previously 
described13.
At birth, information about mode of delivery (spontaneous standard vaginal delivery (SVD), prelabour cae-
sarean section (PCS), induction of labour followed by vaginal delivery (IOL), or emergency caesarean section/
other approaches) child sex, weight (kg) and length (cm) were recorded. Systolic and diastolic blood pressure 
was measured at day 0 and day 1 using a calibrated mobile Trimline aneroid sphygmomanometer (Trimline 
Medical Products Corp, USA). Infant weight and length/height were additionally measured at the follow-up visits 
and z-scores for weight (z-weight), length (z-length) and BMI (z-BMI) were calculated using WHO standards14. 
Breast feeding was assessed as any breast feeding reported by parents at the 6 months visit (or 2 years visit, if the 
information was missing). Information about maternal smoking was collected at 2 years.
cord blood collection and clinical parameters. Cord blood was collected at birth and stored at −80 °C 
until analysis. Glucose, c-peptide, leptin and triglycerides were measured according to previously published 
methods15.
Metabolomics measurements. 136 cord blood samples were measured with a targeted approach at the 
laboratory of the Division of Metabolic and Nutritional Medicine, von Hauner Children’s Hospital, University 
of Munich, Germany. Metabolites were measured as previously described16 (see also supplemental material for 
details).
Each batch included 6 quality control (QC) replicates, pooled from a subset of the test samples; batches and 
analytes with intra-batch coefficient of variation (CV) < 20% (after removal of at most one outlier, defined as QC 
measurement >2 inter-quartile ranges from next measurement) and inter-batch CV < 30% were included in the 
analysis. The inclusion of analytes with at most one batch with 20% < intra-batch CV < 30% and/or inter-batch 
35% was decided on a case by case basis via boxplots inspection. 185 metabolites passed the quality control. 
These included: 22 amino acids (AA), 39 non-esterified fatty acids (NEFA), 41 acylcarnitines (AC, included free 
Carnitine, AC 0), 11 organic acids, 45 phosphatidylcholines (PC: PCaa, with 2 acylester bonds; PCae, with one 
acylester and one ether bond), 7 lyso-PC (LPC) and 20 sphingomyelins (SM). Additional sums and ratios were 
computed: five ratios of AC/AC 0, markers for carnitine palmitoyl-trasferase 1 (CPT1), five ratios of AC 2/long 
chain AC, markers for beta-oxidation, and the sums of NEFA, PCaa, PCae, LPC, total PC and total SM17.
Statistical analysis. All statistical analyses were carried out in R version 3.4.318. To ensure interpretability 
of the findings, only mothers with uncomplicated SVD, planned PCS or IOL and term babies (>37th gestation 
week) were included.
Phenotypic differences. Phenotypic characteristics are presented as median ± interquartile range (IQR), 
or as n (%). Overall group differences for the phenotypic variables were inspected via Kruskal-Wallis tests, for 
continuous variables, or chi-square tests, for categorical variables. If p < 0.1, pairwise comparisons (PCS vs. SVD, 
IOL vs. SVD) were inspected via Wilcoxon test or Fisher’s exact test. For antenatal and perinatal variables, no cor-
rection for multiple testing was applied, as we used this information to select which variables should be included 
in the main models and in the sensitivity analyses. However, we did correct childhood anthropometry measures 
for multiple testing (Bonferroni correction with m = 23, number of total anthropometry measures from 6 months 
until 5 years).
Metabolite differences. Metabolite concentrations were logged; values further away than 4 IQR from the 
median were defined as outliers and removed. Logged metabolite concentrations were used as dependent varia-
bles and mode of delivery (SVD, PCS or IOL) as independent variable in a linear mixed model with random inter-
cept for the batch number (to adjust for batch effects). RCT was not included as model covariate since all groups 
showed similar proportions of mothers in the intervention and control arms (see results section), and since cord 
metabolome was not affected by the intervention16. The following sensitivity analyses were performed: (1) ges-
tational age (GA), child sex, birth weight and maternal BMI were included one by one as additional covariates; 
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(2) the highest and lowest 2.5% of each metabolite were removed (95% central data); (3) IOL babies born before 
the 40th gestational week were excluded. The R packages lme419 and lmerTest20 were used. P-values were adjusted 
for multiple testing using Bonferroni correction for m = 201 (number of analytes, sums and ratios). Metabolites 
associations with p < 0.05/201 ≈ 0.00025 were defined as significant, associations with p < 0.05 as trends. The 
results for the metabolites models are presented in form of Manhattan plots.
Results
phenotypic characteristics. After removing subjects with missing information about mode of delivery, 
cases of emergency caesarean section and pre-term babies (<37th gestational week), 109 subjects were included in 
the analysis. Table 1 presents the participants’ characteristics compared between standard vaginal delivery (SVD, 
n = 76), planned caesarean section (PCS, n = 13) and induction of labour (IOL, n = 20).
SVD, PCS and IOL groups showed no differences with regards to maternal characteristics or RCT arm.
At birth, gestational age (GA) and cord blood (CB) glucose showed differences between the three groups (GA: 
p = 0.005, glucose: p < 0.001). In both cases, PCS was significantly different from SVD, with lower GA (median 
SVD vs. PCS: 282 vs. 277 days, p = 0.015) and lower glucose (4.10 vs. 2.75 mmol/l, p < 0.001); IOL had a trend for 
longer GA (median SVD vs. IOL: 282 vs. 288 days, p = 0.057) but no difference in glucose (4.10 vs. 4.45 mmol/l, 
non-significant (NS)). C-peptide was marginally different in the three groups (p = 0.051) and followed the same 
pattern as glucose (median SVD vs. PCS: 0.41 vs. 0.26 ng/ml, p = 0.017; IOL: 0.41 ng/ml, difference to SVD: NS). 
Leptin was not significantly different among the groups, but its median values tended to be lower in PCS than in 
SVD and IOL babies. Figure 1 shows the boxplot for glucose and C-peptide according to the mode of delivery 
group.
No differences in birth anthropometry or post-natal blood pressure were identified; the median birthweight 
was approximately 4000 g in every group (SVD: 4070 g, PCS: 4005 g, IOL: 4105 g).
The rate of breast-feeding initiation tended to be higher in SVD mothers (80%) than IOL (60%) or PCS (50%) 
(NS) (see Table 1).
No differences between IOL and SVD were observed at any time point, or between SVD and PCS at 6 months 
and 5 years of age, in infant anthropometry. At 2 years of age, PCS children had higher weight (median SVD vs. 
PCS: 12.40 vs. 14.45 kg) and weight-for-age z-scores (0.30 vs. 1.49) than SVD, but these differences were not sig-
nificant after correction for multiple testing.
Metabolomics analysis. Prelabour caesarean section. When compared to SVD, PCS had significantly 
lower NEFA (29 out of 39 species, as well as the total sum of NEFA). AC 18:2 was significantly lower in PCS, with 
other AC (AC 10:2, 12:0, 14:0, 14:1, 16:0 Oxo, 16:1) following the same trend. The sensitivity analyses confirmed 
these results, especially the negative trend for the AC.
Citric and isocitric acid were both lower in the PCS group than in the SVD group. However, due to artefacts in 
the data, citric acid was only significant in the full model, isocitric acid only in the sensitivity analysis. Trends for 
lower levels of phenylalanine, isoleucine, valine and ornithine in the PCS group were observed.
AC 4:0 and alpha-aminoadipic acid tended to be higher in PCS than SVD in the main model, but did not 
pass the sensitivity analysis. The ratios AC 18:0/AC 0 and AC 18:2/AC 0, markers for CPT1 activity, tended to 
be higher and lower, respectively, in the PCS group; only the latter remained evident also after sensitivity analy-
ses. The remaining markers for CPT1 and beta oxidation were lower in the PCS than in the SVD group, but not 
significantly.
Induction of labour. No significant differences were identified between SVD and IOL, but there were trends for 
higher CPT1 activity markers (AC 18:0/AC 0, AC 16:0/AC 0, AC 18:1/AC 0) and NEFA 26:0, and a negative trend 
for free carnitine. NEFA 26:0 and free carnitine did not pass the sensitivity analyses.
Table 2 shows the results for significant metabolites. The results for all metabolites are graphically represented 
in Manhattan plots (Figs. 2 and 3) and the full table is available as supplemental material.
Discussion
Metabolism. In this analysis comprising 109 children from the ROLO study, the cord blood of babies born 
via vaginal delivery, both spontaneously (SVD) or after induction of labour (IOL), showed no differences regard-
ing glucose, c-peptide and leptin concentrations. In the metabolome, no significant differences were identified 
(Fig. 2), but ratios depicting CPT1 activity tended to be higher in IOL babies. CPT1 contributes to transfer long-
chain fatty acids into mitochondria for beta-oxidation21. In this context, enhanced perinatal CPT1 activity can 
be interpreted as preparatory mechanism to postnatal gluconeogenesis, which allows the newborn to transition 
from the continuous supply of nutrients to intermittent feeding22,23. A prerequisite for gluconeogenesis is the 
availability of substrates such as glycogen23, alanine23, and ATP from lipids oxidation24. We hypothesize that IOL 
babies, by receiving an artificially dosed hormonal solicitation in the hours before birth, might initiate fatty acid 
oxidation (FAO) slightly earlier than SVD-born babies, thus the elevated levels of CPT1 activity markers in the 
cord blood. Despite the small magnitude of this effect, this could become relevant particularly when considering 
IOL for mothers with metabolic derangements. The WHO guidelines already discourage performing IOL in 
mothers with (gestational) diabetes with no additional complications, despite recognizing the paucity of data 
available to this theme7.
Prelabour caesarean section (PCS), on the contrary, was associated with profound metabolic changes: most 
notably, the cord blood of PCS babies had significantly lower levels of glucose and NEFA and trends for lower 
C-peptide (used here as marker for fetal insulin) and acylcarnitines (AC) than SVD. The differences in glucose 
and NEFA are already known24; on the other hand, the best of our knowledge, the trends for AC have not been 
reported previously, and only one study observed lower insulin in neonatal sheep born by PCS25. During labour, 
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SVD PCS IOL p-values
n Values n Values n Values Overall
PCS vs. 
SVD
IOL vs. 
SVD
Maternal and paternal variables
RCT group - Intervention 76 32 (42%) 13 6 (46%) 20 13 (65%) NS NS NS
Education - 3rd level at least begun 65 41 (63%) 11 8 (73%) 17 8 (47%) NS NS NS
Maternal age (years) 76 32.95 ± 5.59 13 32.97 ± 1.90 20 32.11 ± 6.35 NS NS NS
Maternal early pregnancy BMI (kg/m2) 76 26.13 ± 5.33 13 25.22 ± 3.88 19 25.75 ± 5.35 NS NS NS
Gestational weight gain (kg) 66 12.10 ± 4.92 11 12.40 ± 2.73 17 13.90 ± 4.40 NS NS NS
HP deprivation index score 2011 76 6.95 ± 12.60 13 10.50 ± 10.70 20 8.10 ± 16.18 NS NS NS
Mother smoking at baseline - yes 76 2 (3%) 13 0 (0%) 20 1 (5%) NS NS NS
Mother smoking at 2 years - yes 39 3 (8%) 6 1 (17%) 9 3 (33%) 0.066 0.448 0.071
Paternal BMI (kg/m2) 35 26.77 ± 4.23 6 30.42 ± 11.82 12 27.84 ± 5.24 NS NS NS
Perinatal variables - anthropometry
Child sex - female 76 42 (55%) 13 6 (46%) 20 9 (45%) NS NS NS
Gestational age (days) 76 282 ± 9.00 13 277 ± 8.00 20 288 ± 11.50 0.005 0.015 0.057
Birth length (cm) 67 52.00 ± 3.00 11 53.00 ± 0.75 17 53.70 ± 3.70 NS NS NS
Birth weight (g) 76 4070 ± 600.00 13 4005 ± 910.00 20 4105 ± 675.00 NS NS NS
Birth waist circumference (cm) 54 33.20 ± 3.08 10 34.00 ± 3.83 15 33.30 ± 2.85 NS NS NS
Birth length-for-age (WHO z-score) 67 1.53 ± 1.61 11 1.91 ± 0.48 17 2.44 ± 1.70 NS NS NS
Birth weight-for-age (WHO z-score) 76 1.59 ± 1.00 13 1.58 ± 1.35 20 1.54 ± 1.21 NS NS NS
Birth weight-for-length (WHO z-score) 67 0.16 ± 1.92 11 0.15 ± 1.16 17 −0.57 ± 2.26 NS NS NS
Birth BMI-for-age (WHO z-score) 67 0.76 ± 1.38 11 0.94 ± 1.36 17 0.42 ± 1.17 NS NS NS
Perinatal variables - no anthropometry
Cord blood glucose (mmol/l) 67 4.10 ± 1.15 12 2.75 ± 0.62 18 4.45 ± 1.30  < 0.0001  < 0.0001 NS
Cord blood C-peptide (ng/ml) 72 0.41 ± 0.98 13 0.26 ± 0.22 20 0.41 ± 0.51 0.051 0.017 NS
Cord blood leptin (ng/ml) 65 24.02 ± 30.15 11 14.48 ± 7.50 16 27.71 ± 27.11 NS NS NS
Cord blood triglycerides (mmol/l) 46 0.47 ± 0.20 8 0.40 ± 0.29 14 0.49 ± 0.32 NS NS NS
Baby diastolic BP (day 0) (mmHg) 72 70 ± 9.00 13 71 ± 8.00 19 70 ± 8.50 NS NS NS
Baby systolic BP (day 0) (mmHg) 72 120 ± 14.25 13 115 ± 10.00 19 120 ± 14.00 NS NS NS
Baby diastolic BP (day 1) (mmHg) 70 70 ± 12.25 13 68 ± 10.00 20 68 ± 12.50 NS NS NS
Baby systolic BP (day 1) (mmHg) 70 110.50 ± 12.25 13 110 ± 18.00 20 115 ± 12.75 NS NS NS
Any breastfeeding - Yes 40 32 (80%) 6 3 (50%) 10 6 (60%) NS NS NS
6 months anthropometry
Child sex - female 47 26 (55%) 9 4 (44%) 11 4 (36%) NS NS NS
Age at 6 m visit (years) 43 0.52 ± 0.08 9 0.51 ± 0.06 10 0.53 ± 0.05 NS NS NS
6 m length* (cm) 47 69.50 ± 3.50 9 69.50 ± 2.50 11 70.00 ± 1.00 NS NS NS
6 m weight* (kg) 47 8.37 ± 1.05 9 8.17 ± 1.21 11 8.60 ± 0.97 NS NS NS
6 m BMI* (kg/m2) 47 17.26 ± 1.57 9 16.91 ± 1.64 11 18.11 ± 1.32 NS NS NS
6 m waist circumference* (cm) 47 44.10 ± 4.20 9 44.00 ± 3.90 11 44.00 ± 2.10 NS NS NS
6 m length-for-age* (WHO z-score) 43 0.93 ± 1.18 9 1.41 ± 0.44 10 1.37 ± 0.36 NS NS NS
6 m weight-for-age* (WHO z-score) 43 0.75 ± 1.07 9 0.52 ± 0.81 10 1.24 ± 0.96 NS NS NS
6 m weight-for-length* (WHO z-score) 47 0.22 ± 1.12 9 −0.05 ± 0.82 11 0.75 ± 0.86 NS NS NS
6 m BMI-for-age* (WHO z-score) 43 −0.03 ± 1.08 9 −0.17 ± 0.83 10 0.71 ± 0.78 NS NS NS
2 years anthropometry
Child sex - female 48 26 (54%) 8 4 (50%) 14 7 (50%) NS NS NS
Age at 2 y visit (years) 48 2.03 ± 0.08 8 2.02 ± 0.07 10 2.04 ± 0.10 NS NS NS
2 y length* (cm) 47 89.00 ± 4.25 8 92.75 ± 4.88 14 89.00 ± 4.25 NS NS NS
2 y weight* (kg) 47 12.40 ± 1.95 8 14.45 ± 1.25 14 13.00 ± 1.90 NS NS NS
2 y BMI* (kg/m2) 47 15.67 ± 2.05 8 16.62 ± 0.77 14 15.99 ± 1.34 NS NS NS
2 y waist circumference* (cm) 46 49.95 ± 5.75 8 51.95 ± 3.90 14 51.90 ± 3.48 NS NS NS
2 y length-for-age* (WHO z-score) 47 0.84 ± 1.28 8 1.80 ± 1.21 10 0.45 ± 1.43 NS NS NS
2 y weight-for-age* (WHO z-score) 47 0.30 ± 0.99 8 1.49 ± 0.64 10 0.43 ± 1.23 NS NS NS
2 y weight-for-length* (WHO z-score) 47 0.00 ± 1.52 8 0.62 ± 0.41 14 0.06 ± 0.95 NS NS NS
2 y BMI-for-age* (WHO z-score) 47 0.00 ± 1.64 8 0.57 ± 0.42 10 −0.32 ± 0.74 NS NS NS
5 years anthropometry
Child sex - female 53 32 (60%) 12 6 (50%) 14 5 (36%) NS NS NS
Age at 5 y visit (years) 53 5.13 ± 0.19 12 5.14 ± 0.09 14 5.14 ± 0.19 NS NS NS
Continued
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in presence of contractions, a plethora of hormones are released by maternal, fetal and placental tissues to enable 
the passage of the baby though the vaginal canal and to prepare the baby for the extrauterine life. Two crucial 
hormones are cortisol and oxytocin. They are secreted both from the mother and the fetus. Fetal cortisol, in par-
ticular, is thought to regulate the adrenergic stimulation at birth22. Catecholamines have been found responsible 
for important postnatal adaptation, among others glucose regulation23,26. Oxytocin is released discontinuously 
both by the maternal pituary gland and the fetus to stimulate uterine contractions during labour27,28 and has been 
observed to stimulate the neonate’s insulin and glucagon secretion in animal models25. Cortisol would thus, via 
adrenergic stimulation, mobilize NEFA and glycogen, initiate the transport of FA for FAO (thus the release of 
mid-chain AC) and ultimately upregulate neonatal glucose levels, while oxytocin favours insulin and glucagon 
secretion for the postnatal glycemic regulation22. The lack of hormonal stimulations during PCS, and specifically 
of the elevated cortisol and oxytocin release, might cause the differences observed for glucose, NEFA, AC, and 
for c-peptide, respectively. The lack of hormonal stimulation, as well as differences in gluconeogenesis initiation, 
have been proposed as causal mechanisms linking PCS to long-term metabolic effects24. Unfortunately, we could 
not test these hypotheses due to lack of hormonal measurements in the study.
As caesarean section is a surgical procedure, parturient women receive a dose of anaesthesia, which can be 
general (mostly via thiopental or, more recently, via propofol29) or regional (spinal or epidural, via bupivacaine30). 
Neonatal differences attributable to the anesthesia are usually transient and not clinically relevant31. However, as 
these drugs can theoretically cross the placenta29,31, a confounding effect of the anaesthesia on the metabolome 
should be considered. For example, Irestedt and colleagues reported that, in babies delivered by PCS, catechola-
mines were higher in the epidural group than in the general anaesthesia group – albeit in both cases values were 
in several orders of magnitude lower than in babies delivered vaginally32. We did not have individual data about 
mode of anaesthesia in our collective, but it is general practice of the National Maternity Hospital to perform PCS 
under spinal anaesthesia. In line to that, a survey conducted in the United States in 2001 showed that “general 
anesthesia was still used in 15–30% of urgent-emergent cesarean deliveries in 2001. However, in elective cesarean 
deliveries, general anesthesia was used in less than 5% of cases in all sizes of hospitals”33. Thus, given the small 
sample size in our population (13 caesarean deliveries), we can assume that most to all PCS in our study were 
SVD PCS IOL p-values
n Values n Values n Values Overall
PCS vs. 
SVD
IOL vs. 
SVD
5 y length* (cm) 51 112.70 ± 6.15 11 112.80 ± 4.40 13 112.30 ± 3.30 NS NS NS
5 y weight* (kg) 51 19.60 ± 3.40 11 21.20 ± 2.30 13 19.00 ± 1.90 NS NS NS
5 y BMI* (kg/m2) 51 15.84 ± 1.69 11 16.15 ± 1.32 13 15.22 ± 1.62 NS NS NS
5 y waist circumference* (cm) 51 53.90 ± 5.60 11 53.20 ± 4.15 13 53.00 ± 4.90 NS NS NS
5 y length-for-age* (WHO z-score) 51 0.40 ± 1.35 11 0.41 ± 0.85 13 0.24 ± 0.64 NS NS NS
5 y weight-for-age* (WHO z-score) 51 0.34 ± 1.09 11 0.83 ± 0.83 13 0.15 ± 0.57 NS NS NS
5 y BMI-for-age* (WHO z-score) 51 0.41 ± 1.07 11 0.66 ± 0.82 13 −0.03 ± 1.23 NS NS NS
Table 1. Characteristics of the studied population. Phenotypic differences are presented as 
median ± interquartile range (IQR), or as n (%). Overall p-values were calculated via Kruskal-Wallis tests, for 
continuous variables, or chi-square tests, for categorical variables. If the overall p < 0.1, pairwise comparisons 
were performed via Wilcoxon test or Fisher’s exact test. P-values for the 23 childhood anthropometry variables 
were adjusted via Bonferroni method (variables marked with *). Abbreviations: SVD: spontaneous vaginal 
delivery; PCS: prelabour caesarean section; IOL: induction of labour; NS: non-significant (p ≥ 0.1).
Figure 1. Cord blood concentrations of glucose (left) and C-peptide (right) according to the mode of delivery 
(SVD: standard vaginal delivery; PCS: prelabour caesarean section; IOL: induction of labour).
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Analyte Analyte group n
PCS IOL
Beta
95% Beta CI 
(Bonferroni)
P-value 
(Bonferroni) Beta
95% Beta CI 
(Bonferroni)
P-value 
(Bonferroni)
14:0 NEFA 109 −0.745 (−1.370, −0.120) 0.004 −0.080 (−0.603, 0.443) 1.000
15:0 NEFA 109 −0.712 (−1.261, −0.160) 8.86e-04 −0.030 (−0.492, 0.434) 1.000
16:0 NEFA 109 −0.526 (−0.901, −0.153) 1.51e-04 −0.022 (−0.344, 0.290) 1.000
16:1 NEFA 109 −0.619 (−1.177, −0.062) 0.014 −0.031 (−0.498, 0.436) 1.000
16:2 NEFA 109 −0.665 (−1.147, −0.182) 2.59e-04 −0.039 (−0.443, 0.365) 1.000
17:0 NEFA 109 −0.582 (−0.973, −0.189) 4.64e-05 0.022 (−0.305, 0.352) 1.000
17:1 NEFA 109 −0.809 (−1.408, −0.204) 4.09e-04 −0.045 (−0.547, 0.469) 1.000
17:2 NEFA 109 −0.691 (−1.176, −0.205) 1.3e-04 0.045 (−0.362, 0.451) 1.000
18:0 NEFA 107 −0.656 (−1.196, −0.118) 0.003 −0.034 (−0.477, 0.402) 1.000
18:1 NEFA 109 −0.563 (−1.036, −0.089) 0.005 −0.031 (−0.428, 0.365) 1.000
18:2 NEFA 109 −0.744 (−1.287, −0.201) 2.92e-04 −0.063 (−0.518, 0.391) 1.000
18:3 NEFA 109 −1.044 (−1.844, −0.244) 7.36e-04 −0.037 (−0.711, 0.629) 1.000
18:4 NEFA 109 −0.932 (−1.610, −0.260) 2.18e-04 −0.016 (−0.595, 0.543) 1.000
19:0 NEFA 109 −0.510 (−0.873, −0.148) 1.62e-04 0.086 (−0.218, 0.390) 1.000
19:1 NEFA 109 −0.634 (−1.094, −0.170) 2.53e-04 −0.061 (−0.446, 0.336) 1.000
20:1 NEFA 109 −0.493 (−0.910, −0.071) 0.005 −0.041 (−0.390, 0.315) 1.000
20:2 NEFA 109 −0.520 (−0.893, −0.147) 2.08e-04 −0.037 (−0.349, 0.275) 1.000
24:0 NEFA 108 −0.498 (−0.991, −0.008) 0.049 −0.070 (−0.491, 0.342) 1.000
24:2 NEFA 109 −0.499 (−0.846, −0.151) 1.03e-04 0.043 (−0.247, 0.335) 1.000
24:4 NEFA 109 −0.469 (−0.842, −0.096) 0.002 −0.020 (−0.332, 0.293) 1.000
24:5 NEFA 109 −0.393 (−0.711, −0.075) 0.002 −0.015 (−0.281, 0.251) 1.000
24:6 NEFA 108 −0.480 (−0.890, −0.078) 0.005 −0.101 (−0.439, 0.223) 1.000
26:4 NEFA 107 −0.314 (−0.580, −0.049) 0.005 0.006 (−0.217, 0.228) 1.000
26:5 NEFA 107 −0.356 (−0.641, −0.071) 0.002 0.015 (−0.224, 0.254) 1.000
AC 18:2 Acylcarnitines 109 −0.498 (−0.940, −0.055) 0.011 −0.007 (−0.377, 0.364) 1.000
Citric acid TCA 107 −0.229 (−0.440, −0.018) 0.020 0.019 (−0.158, 0.196) 1.000
Sum NEFA Sums and Ratios 106 −0.584 (−1.031, −0.146) 5.71e-04 −0.037 (−0.406, 0.317) 1.000
Table 2. Results of the linear models (dependent variable: logged metabolite concentration, independent 
variable: mode of delivery, random intercept for batch number). Beta >0 indicates higher concentration of the 
metabolite in the group PCS or IOL than in SVD (reference group). Only significant associations (Bonferroni-
corrected p-value < 0.05) are presented here; for all metabolites see Supplemental Table 1. Abbreviations: PCS: 
prelabour caesarean section; IOL: induction of labour.
Figure 2. Manhattan plot for the association of metabolites with prelabour caesarean section (PCS) compared 
to standard vaginal delivery (SVD). Associations were calculated via linear mixed models with random 
intercept for batch number.
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performed under local anaesthesia. Therefore, we conclude that our results about PCS are valid under spinal local 
anesthesia, but there might be small differences in case of general or other types of anaesthesia.
In our data, we see that both AC 18:2 and the marker of CPT1 activity involving 18:2 are lower in the cord 
blood of PCS rather than SVD babies. This marked difference involving 18:2 needs attention. While with our 
LC-MS approach we could not distinguish the position of the double bonds, most of the concentration of NEFA 
18:2, and thus AC 18:2, can be attributed to linoleic acid, an omega-6 essential fatty acid (EFA). An impaired pla-
cental transport of long-chain EFA is known to occur in complicated pregnancies (e.g. gestational diabetes mel-
litus or intrauterine growth restriction)34, but our population did not present such cases. A possible explanation 
for this large difference might be due not so much to the PCS in itself, but rather to the usage of NEFA in SVD. 
A kinetic analysis in rat liver has shown that, when several NEFA species are available, CPT1 preferentially uses 
linoleic acid over other species, and especially over stearic acid (18:0, n-9), for turnover into its acylester35. Thus, 
in SVD babies, 18:2 would be the first NEFA to be metabolized into AC, and this would translate into much lower 
values of AC 18:2 and 18:2-CPT1 marker in PCS.
In the published literature, also the CB levels of alanine and of the branched chain amino acids (BCAA) isoleu-
cine (Ile), leucine (Leu) and valine have been reported to be significantly lower in PCS than in SVD36. Alanine, in 
particular, is a preferred substrate for neonatal gluconeogenesis23. Our data only show weak trends for lower Ile, 
Val, ornithine and phenylalanine in PCS than in SVD. This might be explained by considering that our popula-
tion had an elevated birthweight (around 4000 g), which might be associated with increased lipid depots and thus 
the preferred usage of NEFA rather than AA as substrates for gluconeogenesis. Phenylalanine, moreover, can be 
converted into tyrosine, which is a precursor of catecholamines; it is possible that the beginning of labour induces 
phenylalanine secretion in the fetal circulation for catecholamine production, whereas this does not happen in 
PCS. Tyrosine itself was not significantly associated with mode of delivery in our analysis, however it was lower 
in the PCS than in the SVD group.
Anthropometry. As for metabolic markers, we observed no differences in growth and anthropometry up to 
5 years of age between children born by SVD and IOL.
Babies born by PCS had trends for transiently higher weight (and length) z-scores (at 2 years) but these dif-
ferences were not significant after correction for multiple testing and did not persist at 5 years. PCS was mostly 
performed around the 277th gestation day (median), while SVD occurred at the 282nd day, with no significant 
differences in the birthweights. Since elevated fetal weight increases the chance of PCS, it is very plausible that 
enhanced fetal growth, persisting also for some time after birth, might be the reason underlying both the elevated 
infant anthropometry and the earlier gestational age at birth. Unfortunately, the lack of steroid and hormonal 
measurements prevented us from testing this hypothesis.
The available literature about PCS and anthropometry or body mass identifies no consistent differences in 
infancy and childhood, but agrees on a higher risk for overweight in adult age for individuals born by PCS24. 
Our results suggest that mode of delivery does not have a major impact on early growth, but we observed minor 
differences at 2 years. We conjecture that these differences would disappear at 5 years due to lifestyle factors such 
as the child’s physical activity and food preferences37,38, but might reappear later in life, especially during or after 
puberty.
Strengths and limitations. We have studied the impact of caesarean section and, for the first time, induc-
tion of labour, on the cord blood metabolome of 109 mother/child pairs. The mothers in the study had previously 
given birth to a macrosomic child and the studied population was at risk for fetal metabolic dysregulations. As 
pointed out by the WHO, more studies are needed to clarify the implications of IOL with mothers with metabolic 
dysregulations.
Figure 3. Manhattan plot for the association of metabolites with induction of labour (IOL) compared to 
standard vaginal delivery (SVD). Associations were calculated via linear mixed models with random intercept 
for batch number.
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A major limitation of our study is the lack of detailed information about the delivery, especially about the 
type of anaesthesia for caesarean section (general vs. local, anesthetics), the type of induction and the duration 
of labour (possibly broken down in each stage); these pieces of information need to be collected and included 
in future studies tailored to investigate mode of delivery and metabolome. Another limitation of this study was 
the lack of steroid and hormonal measurements, which prevented us from further investigating our hypotheses 
regarding the interplay of fetal growth hormones, fetal stress at parturition, and cord metabolome. Finally, the 
small sample sizes of PCS and IOL vs. SVD might have prevented the identification of more subtle differences in 
the metabolites. However, our study can be used as a starting point for future comparisons, since the metabolomic 
research about mode of delivery has been so far scarce (for PCS) or non-existing (for IOL).
conclusion
In this cohort of secundigravid women with a previous macrosomic child, we have shown that IOL is not asso-
ciated with differences in neonatal metabolism when compared to SVD, except for slightly elevated CPT1 activ-
ity markers, possibly precursor of postnatal gluconeogenesis. Elective PCS, on the contrary, induced profound 
changes in metabolites involved in fatty acid oxidation, glucose and c-peptide neonatal levels, possibly due to the 
lack in adrenergic stimulation and cortisol release. These data might contribute to future research on the impact 
of mode of delivery on short- and long-term metabolic outcomes, which could potentially have important ram-
ifications for child health.
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